Skip to content
Home/Companies/Pharma/Scantox

Scantox

Pharma·Denmark·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Scantox?

Scantox is a Danish Pharma company, currently owned by Impilo since 2021.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Impilo
Investor
Impilo
Impilo Investment Pool 2 · 2021 · Buyout

Key facts

HQDenmark
SectorPharma
StatusActive

More from Impilo Investment Pool 2

Other portfolio companies in the same fund.

Avia Pharma
Active
PharmaSweden· 2024
Qufora
Active
MedTechDenmark· 2024
Tandlaegen.dk
Active
HealthcareDenmark· 2024
Decon
Active
MedTechSweden· 2023
Pelago Bioscience
Active
PharmaSweden· 2023
Stille
Active
MedTechSweden· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Scantox?

Scantox is currently owned by Impilo, through Impilo Investment Pool 2, since 2021.

When did Impilo acquire Scantox?

Impilo acquired Scantox in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue